This invention provides compounds of formula I ##STR00001## that are useful in the treatment or inhibition of LXR mediated diseases.

 
Web www.patentalert.com

< Method and apparatus for determining a molecular descriptor of absorption for a candidate compound

> Aryl sulfamide derivatives and methods of their use

> Benzothiadiazolylphenylalkylamine derivatives and methods of their use
~ 00543